Anemia, Hypochromic: Clinical Trials

61 trials for Anemia, Hypochromic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

61 completed. 61 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 361Completed 61
Phase 26Completed 6

Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic

Trials (filtered) newest first · largest first

All 61 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing
Ferrous sulphate - Iron Deficiency Anemia, Iron Deficiency Anemia Treatment
Phase 3CompletedUniversity of Child Health Sciences and Children's Hospital, Lahore602025-01-072026-06-16
Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman
Low dose IHAT, High Dose IHAT, Carob flour - Iron-deficiency
Phase 3CompletedRDC Clinical Pty Ltd1802024-03-062025-03-10
Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women
Low Dose IHAT, High Dose IHAT, Carob Flour - Iron-deficiency
Phase 3CompletedNemysis Ltd1802024-03-052025-06-04
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Placebo - Anemia, Iron Deficiency, Hyperphosphatemia
Phase 3CompletedUSRC Kidney Research2892022-03-302025-08-29
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric], Placebo - Iron-deficiency, Heart Failure With Preserved Ejection Fraction
Phase 2 / Phase 3CompletedMassachusetts General Hospital652021-11-262026-09-04
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Ferric Maltol, Ferrous sulfate - Anemia, Iron-deficiency
Phase 3CompletedShield Therapeutics652021-11-032025-11-10
Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease
Ferric Maltol, Placebo Oral Capsule - Iron Deficiency Anaemia
Phase 3CompletedJiangsu Aosaikang Pharmaceutical Co., Ltd.1222021-09-012026-07-31
Iron Babies Pilot Supplementation Trial
Iron drops/Ferrous sulphate, Placebo drops - Iron-deficiency, Anaemia in Early Infancy
Phase 3CompletedLondon School of Hygiene and Tropical Medicine1002021-08-032022-05-26
Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)
Ferrous Sulfate, IRONCHILD - Iron Deficiency Anemia, Iron-deficiency
Phase 3CompletedBaylor College of Medicine12021-07-092023-05-06
Local Culture-Based Nutrition Education Intervention on Iron Supplement Tablets (IST) Consumption Compliance in Female Adolescents at Ogan Komering Ilir Regency: A Quasi-Experimental Protocol Study
Iron Supplement Tablets - Anemia, Iron Deficiency Anemia
Phase 3CompletedUniversitas Sriwijaya1262021-07-012023-08-24
Iron Supplementation and Neurodevelopmental Outcome in ELGANs
Iron Sulfate - Iron-deficiency
Phase 3CompletedAnn & Robert H Lurie Children's Hospital of Chicago512021-02-012024-11-12
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
Ferumoxytol Injection [Feraheme], Ferrous Sulfate - Pregnancy Related, Anemia, Iron Deficiency
Phase 3CompletedStanford University832021-01-212026-06-30
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
Iron Carboxymaltose, Iron Isomaltoside, Ferrous sulphate - Postpartum Anemia Nos, Iron-deficiency
Phase 3CompletedUniversity Medical Centre Ljubljana3002020-09-102022-06-27
Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia
Ferrous Fumarate - Iron Deficiency Anemia
Phase 3CompletedPrince of Songkla University662020-01-212022-02-15
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
Ferric carboxymaltose - Iron Deficiency Anemia
Phase 3CompletedAmerican Regent, Inc.72019-11-192022-03-21
Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
Ferric carboxymaltose, Sodium chloride - Iron-deficiency, Transplant-Related Disorder
Phase 3CompletedUniversity Medical Center Groningen1482019-08-022024-08-27
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
Ferric carboxymaltose, Ferrous Sulfate - Iron Deficiency Anemia
Phase 3CompletedAmerican Regent, Inc.792019-01-312022-06-22
Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia
Ferrous Sulfate 300Mg Tablet, Vitamin C 500Mg tablet - Anemia, Iron Deficiency Anemia
Phase 3CompletedSunnybrook Health Sciences Centre512019-01-042025-02-03
Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency
Polyglucoferron, Ferric carboxymaltose, Ferrous Sulfate - Iron Deficiency Anemia
Phase 3CompletedProf. Dr. Frank Behrens1872018-09-182026-01-14
Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students
Lactoferrin, Ferrous sulfate - Iron Deficiency Anemia
Phase 2 / Phase 3Completedyasmin gamal el gendy902018-09-102020-05-28

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Anemia, Iron-Deficiency (61)  ·  Iron Deficiencies (16)  ·  Anemia (15)  ·  Renal Insufficiency, Chronic (8)  ·  Inflammatory Bowel Diseases (5)  ·  Crohn Disease (3)  ·  Colitis, Ulcerative (2)  ·  Heart Failure (2)  ·  Hyperphosphatemia (2)  ·  Hypophosphatemia (2)  ·  Renal Insufficiency (2)  ·  Colorectal Neoplasms (1)  ·  Communicable Diseases (1)  ·  Deficiency Diseases (1)  ·  Disease Progression (1)

Broader conditions

Hematologic Diseases (61)  ·  Hemic and Lymphatic Diseases (61)  ·  Iron Metabolism Disorders (61)  ·  Metabolic Diseases (61)  ·  Nutritional and Metabolic Diseases (61)  ·  Anemia (46)  ·  Iron Deficiencies (45)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Pathologic Processes (10)  ·  Disease Attributes (9)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Kidney Diseases (9)  ·  Male Urogenital Diseases (9)

Interventions

ferric carboxymaltose (17)  ·  ferrous sulfate (13)  ·  Ferric Oxide, Saccharated (8)  ·  iron isomaltoside 1000 (8)  ·  Iron (6)  ·  Iron-Dextran Complex (6)  ·  ferric derisomaltose (6)  ·  ferric maltol (6)  ·  Ferrosoferric Oxide (5)  ·  ferric trimaltol (4)  ·  Saline Solution (3)  ·  Sodium Chloride (2)  ·  ferric citrate (2)  ·  ferroglycine sulfate (2)  ·  locust bean gum (2)

Sponsors

Pharmacosmos A/S (10)  ·  American Regent, Inc. (5)  ·  Shield Therapeutics (5)  ·  AMAG Pharmaceuticals, Inc. (4)  ·  Vifor Pharma (4)  ·  Zeria Pharmaceutical (2)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Baylor College of Medicine (1)  ·  Casa Espirita Terra de Ismael (1)  ·  Denver Nephrologists, P.C. (1)  ·  Federal University of São Paulo (1)  ·  Hospital General Universitario Elche (1)  ·  Institut de Recerca Biomèdica de Lleida (1)  ·  Instituto Nacional de Salud Publica, Mexico (1)  ·  Jiangsu Aosaikang Pharmaceutical Co., Ltd. (1)

Countries

United States (26)  ·  Poland (8)  ·  Canada (6)  ·  Germany (6)  ·  Hungary (6)  ·  Australia (5)  ·  Denmark (5)  ·  Latvia (5)  ·  Spain (5)  ·  India (4)  ·  United Kingdom (4)  ·  Brazil (3)  ·  China (3)  ·  France (3)  ·  Italy (3)

Top investigators

Nicholas Mallard, PhD (2)  ·  Adrian F Hernandez, MD (1)  ·  Amanda Rao, PhD (1)  ·  Bambang B Siswanto, Professor (1)  ·  Carla Cerami, MD, PhD (1)  ·  Christoph Gasche, Professor (1)  ·  David Kearney, MD (1)  ·  Deirdre Lyell (1)  ·  Dr.Yulia Lin (1)  ·  Drora Fraser, PhD (1)  ·  Gary Hoel, RPh, PhD (1)  ·  Geoff Block, MD (1)  ·  Geoffrey A Block, MD (1)  ·  Greg Lewis, MD (1)

Results publications

PMID 19920054, PMID 25545376, PMID 27237709, PMID 32016310, PMID 19875408, PMID 20016011, PMID 24891437, PMID 25639592, PMID 26028263, PMID 26843085, PMID 27068478, PMID 28095881, PMID 28339831, PMID 29958570, PMID 30518682, PMID 31243803, PMID 32049331, PMID 34003690, PMID 34029682, PMID 35771891, PMID 36578916, PMID 36874582, PMID 36948568, PMID 37598795, PMID 37632463, PMID 38250799, PMID 39890013, PMID 40576086, PMID 41137844, PMID 41860281, PMID 42733564

NIH funding

2014 (1), 2016 (1), K12HD103084 (1), K23HL132001 (1), R01HL151841 (1)